美國,Biosearch Technologies,
Biosearch Technologies是專業性熒光定量PCR探針合成及標記服務公司,提供與世界上各種熒光定量PCR儀配套的探標記方式及熒光素。
Biosearch Technologies的根源可以追溯到1978年,現任總裁兼首席執行官羅恩 - 庫克,博士創立了“Biosearch”,為新興的生物技術產業提供研究工具。在20世紀80年代,Biosearch自主研發固相DNA合成器,如SAM I, the Cyclone, Biosearch 8700 and Biosearch 8800 Prep。這些生產制造的寡核苷酸的技術,催生新寡核苷酸技術的發展。最引人注目的是1982年,Kary Mullis在Cetus 公司使用了BiosearchSAM I合成DNA創造使用的寡核苷酸,其最終導致的聚合酶鏈反應(PCR)的發現。
Biosearch Technologies commits itself to perfecting the design and manufacture of innovative nucleic acid based products that accelerate the discovery and application of genomic information. We strive for the highest levels of product quality and customer satisfaction in the diverse markets to which we cater worldwide.
Quality Reagents for Quality Science
Product quality is of utmost importance to us. At Biosearch, we are acutely aware of the time, effort and money our customers invest in their work. Poor quality reagents can ruin even the best-designed experiments. Our commitment to quality is a direct result of this awareness. From the receiving dock to the shipping dock to your lab bench, we have developed exhaustive quality assurance protocols that test and document each important physical parameter of every compound that enters and leaves our labs. Starting with the basic raw materials and ending with the final highly-purified end product, we maintain purity and quality documentation that ships with every product we sell.